• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制药行业的可持续性:寻求整体视角。

Sustainability in the biopharmaceutical industry: Seeking a holistic perspective.

机构信息

Department of Process & Chemical Engineering, University College Cork, Ireland.

Department of Process & Chemical Engineering, University College Cork, Ireland.

出版信息

Biotechnol Adv. 2019 Sep-Oct;37(5):698-707. doi: 10.1016/j.biotechadv.2019.03.015. Epub 2019 Mar 26.

DOI:10.1016/j.biotechadv.2019.03.015
PMID:30922993
Abstract

Biopharmaceuticals manufacturing is a critical component of the modern healthcare system, with emerging new treatments composed of increasingly complex biomolecules offering solutions to chronic and debilitating disorders. While this sector continues to grow, it strongly exhibits "boom-to-bust" performance which threatens its long-term viability. Future trends within the industry indicate a shift towards continuous production systems using single use technologies that raises sustainability issues, yet research in this area is sparse and lacks consideration of the complex interactions between environmental, social and economic concerns. The authors outline a sustainability-focused vision and propose opportunities for research to aid the development of a more integrated approach that would enhance the sustainability of the industry.

摘要

生物制药制造是现代医疗保健系统的关键组成部分,新兴的新治疗方法由越来越复杂的生物分子组成,为慢性和衰弱性疾病提供了解决方案。虽然该行业持续增长,但它表现出强烈的“繁荣-萧条”性能,这威胁到其长期生存能力。该行业的未来趋势表明,将转向使用一次性技术的连续生产系统,这引发了可持续性问题,但该领域的研究很少,并且没有考虑到环境、社会和经济问题之间的复杂相互作用。作者概述了一个以可持续性为重点的愿景,并提出了研究机会,以帮助开发更具综合性的方法,从而提高该行业的可持续性。

相似文献

1
Sustainability in the biopharmaceutical industry: Seeking a holistic perspective.生物制药行业的可持续性:寻求整体视角。
Biotechnol Adv. 2019 Sep-Oct;37(5):698-707. doi: 10.1016/j.biotechadv.2019.03.015. Epub 2019 Mar 26.
2
The state of biopharmaceutical manufacturing.生物制药制造的现状。
Biotechnol Annu Rev. 2003;9:285-302. doi: 10.1016/s1387-2656(03)09008-2.
3
Mammalian cell culture capacity for biopharmaceutical manufacturing.哺乳动物细胞培养在生物制药生产中的应用。
Adv Biochem Eng Biotechnol. 2014;139:185-225. doi: 10.1007/10_2013_215.
4
Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.迈向欧洲药品研究战略(2014-2020 年):欧盟制药工业协会联合会关于“地平线 2020”计划的立场文件。
Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6.
5
Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.连续生物制药生产设施的产量优化
PDA J Pharm Sci Technol. 2017 May-Jun;71(3):189-205. doi: 10.5731/pdajpst.2016.006882. Epub 2016 Dec 14.
6
Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.连续制药生产中的控制系统工程。2014年5月20 - 21日,连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):832-9. doi: 10.1002/jps.24311. Epub 2014 Dec 26.
7
Industrialization of mAb production technology: the bioprocessing industry at a crossroads.单克隆抗体生产技术的产业化:生物加工行业的十字路口。
MAbs. 2009 Sep-Oct;1(5):443-52. doi: 10.4161/mabs.1.5.9448. Epub 2009 Sep 16.
8
The biopharmaceutical industry in China: history and future perspectives.中国的生物制药产业:历史与未来展望。
Front Med. 2012 Jun;6(2):101-11. doi: 10.1007/s11684-012-0191-9. Epub 2012 Apr 28.
9
Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.分批补料和灌注培养工艺:不确定性下的经济、环境和运行可行性。
Biotechnol Bioeng. 2013 Jan;110(1):206-19. doi: 10.1002/bit.24608. Epub 2012 Aug 6.
10
Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.设备与分析公司面临持续挑战。2014年5月20 - 21日 连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):821-31. doi: 10.1002/jps.24282. Epub 2014 Dec 1.

引用本文的文献

1
Application of a Rational Crystal Contact Engineering Strategy on a Poly(ethylene terephthalate)-Degrading Cutinase.一种合理的晶体接触工程策略在聚对苯二甲酸乙二酯降解角质酶上的应用
Bioengineering (Basel). 2025 May 23;12(6):561. doi: 10.3390/bioengineering12060561.
2
Rational Introduction of Electrostatic Interactions at Crystal Contacts to Enhance Protein Crystallization of an Ene Reductase.合理引入晶体接触处的静电相互作用以增强烯还原酶的蛋白质结晶
Biomolecules. 2025 Mar 22;15(4):467. doi: 10.3390/biom15040467.
3
Multiple Use of Regenerated Depth Filters in Antibody Purification Processes.
再生深度过滤器在抗体纯化过程中的多次使用。
Biotechnol Bioeng. 2025 Jun;122(6):1366-1375. doi: 10.1002/bit.28957. Epub 2025 Feb 24.
4
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii.去糖基化单克隆抗体的改造以提高在毕赤酵母中的生产能力
Biotechnol Bioeng. 2025 Feb;122(2):361-372. doi: 10.1002/bit.28878. Epub 2024 Nov 14.
5
Burden Imposed by Heterologous Protein Production in Two Major Industrial Yeast Cell Factories: Identifying Sources and Mitigation Strategies.两种主要工业酵母细胞工厂中异源蛋白生产带来的负担:确定来源及缓解策略
Front Fungal Biol. 2022 Feb 1;3:827704. doi: 10.3389/ffunb.2022.827704. eCollection 2022.
6
Efficient Isolation of Bacterial RNAs Using Silica-Based Materials Modified with Ionic Liquids.使用离子液体修饰的硅基材料高效分离细菌RNA
Life (Basel). 2021 Oct 15;11(10):1090. doi: 10.3390/life11101090.
7
Divisive Faultlines and Knowledge Search in Technological Innovation Network: An Empirical Study of Global Biopharmaceutical Firms.技术创新网络中的分裂断层与知识搜索:全球生物制药公司的实证研究
Int J Environ Res Public Health. 2021 May 24;18(11):5614. doi: 10.3390/ijerph18115614.
8
Bioengineering tools for the production of pharmaceuticals: current perspective and future outlook.生物工程工具在药物生产中的应用:当前视角与未来展望。
Bioengineered. 2019 Dec;10(1):469-492. doi: 10.1080/21655979.2019.1682108.